These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 35967878)
21. Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi. Michailowsky V; Murta SM; Carvalho-Oliveira L; Pereira ME; Ferreira LR; Brener Z; Romanha AJ; Gazzinelli RT Antimicrob Agents Chemother; 1998 Oct; 42(10):2549-56. PubMed ID: 9756754 [TBL] [Abstract][Full Text] [Related]
22. Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant Fonseca-Berzal C; da Silva CF; Batista DDGJ; de Oliveira GM; Cumella J; Batista MM; Peres RB; Silva da Gama Nefertiti A; Escario JA; Gómez-Barrio A; Arán VJ; Soeiro MNC Parasitology; 2020 Sep; 147(11):1216-1228. PubMed ID: 32530391 [TBL] [Abstract][Full Text] [Related]
23. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi. Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654 [TBL] [Abstract][Full Text] [Related]
24. Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations. Lima DA; Gonçalves LO; Reis-Cunha JL; Guimarães PAS; Ruiz JC; Liarte DB; Murta SMF Parasit Vectors; 2023 May; 16(1):167. PubMed ID: 37217925 [TBL] [Abstract][Full Text] [Related]
25. Drug transporter and oxidative stress gene expression in human macrophages infected with benznidazole-sensitive and naturally benznidazole-resistant Trypanosoma cruzi parasites treated with benznidazole. Téllez J; Romero I; Romanha AJ; Steindel M Parasit Vectors; 2019 May; 12(1):262. PubMed ID: 31126349 [TBL] [Abstract][Full Text] [Related]
26. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi. Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419 [TBL] [Abstract][Full Text] [Related]
27. Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy. Silva Grijó Farani P; Iandra da Silva Ferreira B; Begum K; Vilar-Pereira G; Pereira IR; Fernández-Figueroa EA; Cardenas-Ovando RA; Almeida IC; Roy S; Lannes-Vieira J; Moreira OC PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011223. PubMed ID: 36972298 [TBL] [Abstract][Full Text] [Related]
28. In-vivo treatment with benznidazole enhances phagocytosis, parasite destruction and cytokine release by macrophages during infection with a drug-susceptible but not with a derived drug-resistant Trypansoma cruzi population. Murta SM; Ropert C; Alves RO; Gazzinelli RT; Romanha AJ Parasite Immunol; 1999 Oct; 21(10):535-44. PubMed ID: 10610497 [TBL] [Abstract][Full Text] [Related]
29. Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole. Caldas IS; da Matta Guedes PM; dos Santos FM; de Figueiredo Diniz L; Martins TA; da Silva do Nascimento AF; Azevedo MA; de Lima WG; Neto RM; Torres RM; Talvani A; Bahia MT Trop Med Int Health; 2013 Jan; 18(1):75-84. PubMed ID: 23107306 [TBL] [Abstract][Full Text] [Related]
30. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease. Moreno M; D'ávila DA; Silva MN; Galvão LM; Macedo AM; Chiari E; Gontijo ED; Zingales B Mem Inst Oswaldo Cruz; 2010 Nov; 105(7):918-24. PubMed ID: 21120364 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi. Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon. Teston APM; Fernandes NS; Abegg CP; de Abreu AP; Sarto MPM; Gomes ML; Toledo MJO Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400 [TBL] [Abstract][Full Text] [Related]
34. Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates. Quebrada Palacio LP; González MN; Hernandez-Vasquez Y; Perrone AE; Parodi-Talice A; Bua J; Postan M PLoS One; 2018; 13(9):e0203462. PubMed ID: 30183775 [TBL] [Abstract][Full Text] [Related]
35. Improved efficacy and safety of low doses of benznidazole-loaded multiparticulate delivery systems in experimental Chagas disease therapy. García MC; Eberhardt N; Sanmarco LM; Ponce NE; Jimenez-Kairuz AF; Aoki MP Eur J Pharm Sci; 2021 Sep; 164():105912. PubMed ID: 34133985 [TBL] [Abstract][Full Text] [Related]
37. Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy. Simões-Silva MR; De Araújo JS; Oliveira GM; Demarque KC; Peres RB; D'Almeida-Melo I; Batista DGJ; Da Silva CF; Cardoso-Santos C; Da Silva PB; Batista MM; Bahia MT; Soeiro MNC Biochem Pharmacol; 2017 Dec; 145():46-53. PubMed ID: 28870526 [TBL] [Abstract][Full Text] [Related]
38. 4-nitrobenzoylcoumarin potentiates the antiparasitic, anti-inflammatory and cardioprotective effects of benznidazole in a murine model of acute Trypanosoma cruzi infection. Vilas-Boas DF; Oliveira RRG; Gonçalves-Santos E; Silva LS; Diniz LF; Mazzeti AL; Brancaglion GA; Carvalho DT; Caldas S; Novaes RD; Caldas IS Acta Trop; 2022 Apr; 228():106314. PubMed ID: 35038424 [TBL] [Abstract][Full Text] [Related]